Bergersen, Kristina V.
Pham, Kathy
Li, Jiang
Ulrich, Michael T.
Merrill, Patrick
He, Yuxin
Alaama, Sumaya
Qiu, Xinru
Harahap-Carrillo, Indira S.
Ichii, Keita
Frost, Shyleen
Kaul, Marcus
Godzik, Adam
Heinrich, Erica C.
Nair, Meera G.
Funding for this research was provided by:
UCR Opportunities to Advance Sustainability Innovation and Social Inclusion (OASIS) Internal Award
National Institutes of Health (U54 MD013368, U54 MD013368, U54 MD013368, U54 MD013368, U54 MD013368)
National Institutes of Health SIG grant (S10 OD026929, S10 OD026929)
UCR startup
Article History
Received: 11 April 2023
Accepted: 5 August 2023
First Online: 19 August 2023
Declarations
:
: This study was approved by the institutional review boards (IRB) of Riverside University Health System Medical Center (RUHS) and the University of California Riverside (UCR) (HS-20–121 and HS-20–128). Study participants were informed of the risks of participation and provided written informed consent in their native language, English or Spanish. For some ICU patients who were unable to provide consent, written informed consent was waived by the IRB committee at RUHS (HS-20–121), and instead, a designated surrogate decision-maker provided written consent. This study complies with the <i>Declaration of Helsinki</i>, except for registration in a database.
: Not applicable.
: The authors declare no competing interests.